These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8051163)

  • 1. Characterization of the cellular binding site for the urinary trypsin inhibitor.
    Kobayashi H; Gotoh J; Fujie M; Terao T
    J Biol Chem; 1994 Aug; 269(32):20642-7. PubMed ID: 8051163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition.
    Kobayashi H; Gotoh J; Kanayama N; Hirashima Y; Terao T; Sugino D
    Cancer Res; 1995 May; 55(9):1847-52. PubMed ID: 7728751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cell membrane-associated urinary trypsin inhibitor in tumor cell invasion and metastasis.
    Kobayashi H; Terao T
    Oncol Rep; 1997; 4(1):65-72. PubMed ID: 21590013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
    Kobayashi H; Shinohara H; Takeuchi K; Itoh M; Fujie M; Saitoh M; Terao T
    Cancer Res; 1994 Feb; 54(3):844-9. PubMed ID: 8306348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-alpha-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface.
    Kobayashi H; Gotoh J; Hirashima Y; Terao T
    J Biol Chem; 1996 May; 271(19):11362-7. PubMed ID: 8626690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor.
    Kobayashi H; Hirashima Y; Sun GW; Fujie M; Shibata K; Tamotsu S; Miura K; Sugino D; Tanaka Y; Kondo S; Terao T
    Biochim Biophys Acta; 1998 Apr; 1383(2):253-68. PubMed ID: 9602143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
    Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
    Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
    Kobayashi H; Gotoh J; Terao T
    Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
    Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
    J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
    Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
    Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Fujie M; Nishida T; Takigawa M; Terao T
    J Biol Chem; 2001 Apr; 276(17):13650-6. PubMed ID: 11278581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human myometrial cells in culture express specific binding sites for urinary trypsin inhibitor.
    Kobayashi H; Hirashima Y; Terao T
    Mol Hum Reprod; 2000 Aug; 6(8):735-42. PubMed ID: 10908284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Terao T
    Biochim Biophys Acta; 2001 May; 1547(1):26-36. PubMed ID: 11343788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of urokinase and urinary trypsin inhibitor in metastatic and non-metastatic murine Lewis lung carcinoma cells.
    Kobayashi H; Gotoh J; Hirashima Y; Terao T
    Int J Oncol; 1996 Apr; 8(4):757-63. PubMed ID: 21544423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
    Kobayashi H; Sugino D; Terao T
    Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity of urinary trypsin inhibitor-binding protein to link protein.
    Kobayashi H; Hirashima Y; Sun GW; Fujie M; Nishida T; Takigawa M; Terao T
    J Biol Chem; 2000 Jul; 275(28):21185-91. PubMed ID: 10801881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
    Sugimura M; Kobayashi H; Terao T
    Gynecol Oncol; 1994 Mar; 52(3):337-46. PubMed ID: 7512520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.
    Kobayashi H; Shinohara H; Gotoh J; Fujie M; Fujishiro S; Terao T
    Br J Cancer; 1995 Nov; 72(5):1131-7. PubMed ID: 7577458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.